to develop class II HDAC inhibitors as therapeutics for treating metabolic disorders. Given that pharmacological HDAC inhibitors are already in development as potential anticancer agents, this strategy seems particularly promising. Importantly, the two new studies also raise a number of complex questions that are critical to understanding the regulation of metabolic homeostasis. First, the studies highlight the importance of acetylation in controlling Foxo function. Given Foxo's involvement in numerous physiological processes, this regulatory mechanism is expected to influence not only metabolism but also cell growth, proliferation, apoptosis, and longevity. However, the relative contributions of Sirtuins and class IIa HDACs for controlling Foxo activity still remain unknown. It will also be important to understand why gluconeogenic gene expression is regulated by two distinct pathways: HDAC inhibition by AMPK/SIK1/2 and CRTC2 inhibition by SIK1/2. One speculation is that the perceived redundancy allows intricate, context-dependent regulation of gluconeogenesis or of Foxo function more generally. Finally, the physiologic consequences of this regulatory mechanism might reach beyond glucose and lipid homeostasis and may include Foxomediated control of life span, cell survival, and growth. The combined power of Drosophila and mouse genetics will clearly provide key insights into these intriguing questions.
Bridging a gap between transcriptomics and the study of cis-acting elements (cistromics), Hah et al. (2011) apply a next-generation sequencing technique to gain an unprecedented view of the changes in RNA synthesis that occur following estrogen receptor activation in human breast cancer cells.
The regulation of eukaryotic gene expression is remarkably complex, with the transcriptome in any given cell affected by the epigenome, which is acted upon by transcription factors binding to cis-acting elements (the cistrome) and RNA polymerases that generate messenger RNAs (mRNAs) (Figure 1 ). In this issue, Hah et al. (2011) bridge transcriptomics and cistromics to provide surprising insights into the genome-wide distribution and dynamics of transcription in response to an external stimulus-in this case, the exposure of human breast cancer cells to the hormone estrogen.
Techniques based on next-generation sequencing, most notably chromatin immunoprecipitation sequencing (ChIPseq) and RNA-seq are greatly contributing to our understanding of transcriptional regulation. ChIP-seq enables researchers to localize transcription factor binding or specific nucleosome structures defining cistromes in a given cell type or tissue under different conditions (Lupien and Brown, 2009 ). RNA-seq makes it possible to assay many species of transcripts, including mRNAs, noncoding RNAs, and small RNAs, while providing exact information about alternative splice variants in the surveyed biological sample (Ozsolak and Milos, 2011) . Although combining these approaches is a powerful means of gaining biological insights, one limitation is that transcriptomes represent steady-state mRNA levels, which are determined by the rate of mRNA synthesis divided by the rate of mRNA degradation. RNA degradation is highly regulated, leading to posttranscriptional alteration of gene expression that is largely independent of the cistromes that govern mRNA synthesis. Thus, to appreciate the true impact of the cistromes, there is a need to measure the synthesis of nascent RNA molecules and thereby the numerator of the ''mRNA synthesis/mRNA degradation'' equation (Figure 1 ).
Lis and colleagues recently invented a technique to address this gap. Called GRO-Seq (genome-wide nuclear run-on followed by next-generation sequencing) (Core et al., 2008) , it is based on classical nuclear run-on experiments in which ongoing transcription is studied in isolated nuclei under conditions that allow labeling of nascent, actively transcribed RNA molecules, which can now be purified and deeply sequenced in a genome-wide manner. More recently, this lab employed GROseq to compare the distribution of transcriptionally engaged RNA polymerase 2 (Pol 2) in embryonic stem cells and differentiated mouse embryonic fibroblasts (Min et al., 2011) . In another study, GROseq was used to demonstrate that the male-specific lethal (MSL) complex in Drosophila enhances transcription by facilitating the progression of Pol2 across active X-linked genes, thus contributing to new understanding of sex-specific gene dosage differences on X chromosomes (Larschan et al., 2011) . Hah et al. now utilize GRO-seq to provide exciting new insights into hormone action.
The authors measure the instantaneous rate of RNA synthesis in MCF-7 human breast cancer cells treated with 17b-estradiol (E2), a natural ligand of the estrogen receptor, for 10, 40, and 160 min. Using new bioinformatic algorithms for transcript calling and quantitation, the authors report numerous insights into estrogen receptor signaling and transcriptional regulation in general, some of which relate directly to the difference between measuring the rate of transcription versus the level of mature transcript.
For example, a surprisingly high percentage (26%) of transcripts active at one or more time point during the experiment were regulated by E2 treatment, whereas 10% respond after only 10 min. In addition, direct comparison of transcription rate with steady-state transcriptomes (from microarrays) shows that the synthesis of protein-coding transcripts is transiently responsive to E2 in contrast to the gradual increase in mRNA levels. Further, the promoters of most genes that are maximally induced at later time points are first loaded with Pol2, and only later does the GRO-seq signal extend into the gene body. These insights into the kinetics of transcription cannot be gleaned from measuring steady-state mRNA levels that take hours to accumulate. Moreover, owing to the large number of nongenic transcripts detected, the GROseq method was able to assign three to four times more of the ERa cistrome to transcribed regions than was possible using transcriptome data (Welboren et al., 2009; Carroll et al., 2006) . GRO-seq also reveals new aspects of transcription that cannot be learned by ChIPseq for Pol2. Some 16% of the transcripts stem from divergent transcription, a phenomenon that has recently been shown to be widespread in the genome and may promote a nucleosome-poor environment at promoters where transcriptional rates need to be high (Seila et al., 2009) . Consistent with this, E2 regulates hundreds of divergent transcripts that correlate with accumulation of the protein-coding mRNA. In addition, Hah et al. uncover antisense transcription and transcripts from Pol1 and Pol3-some regulated by E2-that cannot be identified by Pol2 ChIP-seq because it does not deliver strand-specific information.
The authors also noted short pieces of RNA transcribed from enhancers, as was recently observed in neurons using RNAseq and Pol 2 ChIP-seq (Kim et al., 2010) . The observation of RNAs emanating from enhancers using different methods in very different cell systems suggests their general existence. Although their function remains obscure, their locations are consistent with the finding of ER and other transcription factors at enhancers far from transcription start sites (the ''dark matter'' of the genome) that has been one of the major surprises of cistromics.
It is clear that transcriptome analyses, especially RNA-seq, will continue to provide valuable biological information. Logic Estradiol-bound dimers of the estrogen receptor bind either at distal enhancers or at promoters of their target genes, thereby defining the estrogen receptor (ER) cistrome. This binding leads to initiation of transcription by RNA polymerase 2 (Pol2) and eventually to synthesis of nascent RNA chains. The steady-state of the cytoplasmic RNA pool-the transcriptome-is determined by the rate of RNA synthesis divided by the rate of RNA degradation. GRO-seq (genome-wide nuclear run-on followed by next-generation sequencing) connects the cistrome and the transcriptome by mapping the quantity and genome-wide distribution of transcriptionally engaged RNA polymerases. PIC, preinitiation complex; TSS, transcription start site.
suggests that steady-state protein levels, which largely determine cellular functions, will correlate better with steady-state mRNA levels than with the rate of mRNA transcription, although this should be formally proven. But for those interested in the direct effects of transcription factors or of the environment (including hormonal signals) upon transcription, the ability to measure the rates of RNA synthesis in a genome-wide mannerthe ''RNA synthesome''-opens new doors to discovery.
